Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenna B Emerson

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Obstetrics and Gynecology Clinics of North America|January 27, 2019
Less Is More: Minimally Invasive and Quality Surgical Management of Gynecologic CancerEvelyn Cantillo, Jenna B Emerson, Cara Mathews
Obstetrics and Gynecology|August 6, 2015
Third-Trimester Prenatal Syphilis Screening: A Cost-Effectiveness AnalysisCatherine M Albright, Jenna B Emerson, Erika F Werner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 15, 2023
Acceptability of human papillomavirus self-collection and the role of telehealth: a prospective, randomized study stratified by menopausal statusKatherine Fitch, Jacqueline A Bohn, Jenna B Emerson, et al.
Obstetrics and Gynecology|December 8, 2017
Opioid Knowledge and Prescribing Practices Among Obstetrician-GynecologistsAnnetta M Madsen, Lauren M Stark, Phinnara Has, et al.
Rhode Island Medical Journal (2013)|August 6, 2020
Outpatient Opioid Use After Cesarean DeliveryJenna B Emerson, Valery A Danilack, Amita Kulkarni, et al.
Oncology Letters|May 9, 2022
Intratumoral expression analysis reveals that OX40 and TIM-3 are prominently expressed and have variable associations with clinical outcomes in high grade serous ovarian cancerNicole E James, Ashley D Valenzuela, Jenna B Emerson, et al.
Obstetrics and Gynecology|November 10, 2015
Gender Differences in Scholarly Productivity Within Academic Gynecologic Oncology DepartmentsEmily K Hill, Rachel A Blake, Jenna B Emerson, et al.
Oncotarget|June 6, 2019
Inhibition of DUSP6 sensitizes ovarian cancer cells to chemotherapeutic agents via regulation of ERK signaling response genesNicole E James, Lindsey Beffa, Matthew T Oliver, et al.
Scientific Reports|May 24, 2020
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genesNicole E James, Jenna B Emerson, Ashley D Borgstadt, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Obstetrics and Gynecology Clinics of North America|January 27, 2019
Less Is More: Minimally Invasive and Quality Surgical Management of Gynecologic CancerEvelyn Cantillo, Jenna B Emerson, Cara Mathews
Obstetrics and Gynecology|August 6, 2015
Third-Trimester Prenatal Syphilis Screening: A Cost-Effectiveness AnalysisCatherine M Albright, Jenna B Emerson, Erika F Werner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 15, 2023
Acceptability of human papillomavirus self-collection and the role of telehealth: a prospective, randomized study stratified by menopausal statusKatherine Fitch, Jacqueline A Bohn, Jenna B Emerson, et al.
Obstetrics and Gynecology|December 8, 2017
Opioid Knowledge and Prescribing Practices Among Obstetrician-GynecologistsAnnetta M Madsen, Lauren M Stark, Phinnara Has, et al.
Rhode Island Medical Journal (2013)|August 6, 2020
Outpatient Opioid Use After Cesarean DeliveryJenna B Emerson, Valery A Danilack, Amita Kulkarni, et al.
Oncology Letters|May 9, 2022
Intratumoral expression analysis reveals that OX40 and TIM-3 are prominently expressed and have variable associations with clinical outcomes in high grade serous ovarian cancerNicole E James, Ashley D Valenzuela, Jenna B Emerson, et al.
Obstetrics and Gynecology|November 10, 2015
Gender Differences in Scholarly Productivity Within Academic Gynecologic Oncology DepartmentsEmily K Hill, Rachel A Blake, Jenna B Emerson, et al.
Oncotarget|June 6, 2019
Inhibition of DUSP6 sensitizes ovarian cancer cells to chemotherapeutic agents via regulation of ERK signaling response genesNicole E James, Lindsey Beffa, Matthew T Oliver, et al.
Scientific Reports|May 24, 2020
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genesNicole E James, Jenna B Emerson, Ashley D Borgstadt, et al.
Pageof 1